Publications by authors named "Veronique Lorgis"

26Publications

Complementary and alternative medicine use in glioma patients in France.

J Neurooncol 2019 Dec 21;145(3):487-499. Epub 2019 Oct 21.

Department of Neurology, University Hospital and University of Zurich, Frauenklinikstrasse 26, 8091, Zurich, Switzerland.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s11060-019-03315-8DOI Listing
December 2019

[The anti-tumor immune response in breast cancer: Update and therapeutic perspectives].

Ann Pathol 2017 Feb 31;37(1):133-141. Epub 2017 Jan 31.

Département d'oncologie médicale, centre Georges-François-Leclerc, 21000 Dijon, France; Plateforme de transfert en biologie cancérologique, centre Georges-François-Leclerc, 21000 Dijon, France; UMR Inserm U866, faculté de médecine de Dijon, 21000 Dijon, France; UFR des sciences de santé, 21000 Dijon, France; Université de Bourgogne, 21000 Dijon, France.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.annpat.2016.12.012DOI Listing
February 2017

[CEA and early detection of relapse in breast cancer subtypes: Comparison with CA 15-3].

Bull Cancer 2016 May 8;103(5):434-43. Epub 2016 Mar 8.

Centre Georges-François-Leclerc, département d'oncologie médicale, 1, rue de Pr.-Marion, 21079 Dijon cedex, France.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.bulcan.2016.02.003DOI Listing
May 2016

[Clinical value of CA 15-3 for early detection of relapse in locally advanced breast cancer].

Bull Cancer 2015 Oct 28;102(10):834-44. Epub 2015 Sep 28.

Centre Georges-François-Leclerc, département de biologie et pathologie des tumeurs, 1, rue de Pr.-Marion, 21079 Dijon cedex, France. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.bulcan.2015.07.011DOI Listing
October 2015

Identification of Biomarkers Including 18FDG-PET/CT for Early Prediction of Response to Neoadjuvant Chemotherapy in Triple-Negative Breast Cancer.

Clin Cancer Res 2015 Dec 30;21(24):5460-8. Epub 2015 Jun 30.

Department of Nuclear Medicine, Centre GF Leclerc, Dijon, France. Université de Bourgogne, UMR CNRS 6306, Dijon, France. Imaging Department, CHU Le Bocage, Dijon, France.

View Article

Download full-text PDF

Source
http://clincancerres.aacrjournals.org/cgi/doi/10.1158/1078-0
Publisher Site
http://dx.doi.org/10.1158/1078-0432.CCR-15-0384DOI Listing
December 2015

FOLFIRI plus bevacizumab as a second-line therapy for metastatic intrahepatic cholangiocarcinoma.

World J Gastroenterol 2015 Feb;21(7):2096-101

Jean-Florian Guion-Dusserre, Veronique Lorgis, Julie Vincent, Leila Bengrine, Francois Ghiringhelli, Department of Medical Oncology, Centre Georges-François Leclerc, 21000 Dijon, France.

View Article

Download full-text PDF

Source
http://www.wjgnet.com/1007-9327/full/v21/i7/2096.htm
Publisher Site
http://dx.doi.org/10.3748/wjg.v21.i7.2096DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4326145PMC
February 2015

FOLFIRINOX bevacizumab is a promising therapy for chemorefractory metastatic colorectal cancer.

Oncology 2014 8;87(3):148-58. Epub 2014 Jul 8.

Department of Medical Oncology, Centre Georges-François Leclerc, CRI-866 University of Burgundy, Dijon, France.

View Article

Download full-text PDF

Source
https://www.karger.com/Article/FullText/361031
Publisher Site
http://dx.doi.org/10.1159/000361031DOI Listing
September 2014

Hepatic arterial infusion of gemcitabine plus oxaliplatin as second-line treatment for locally advanced intrahepatic cholangiocarcinoma: preliminary experience.

Chemotherapy 2013 9;59(5):354-60. Epub 2014 May 9.

Department of Medical Oncology, Centre Georges-François Leclerc, Dijon, France.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1159/000362223DOI Listing
January 2015

Prognostic value of chemotherapy-induced hematological toxicity in metastatic colorectal cancer patients.

World J Gastroenterol 2014 Feb;20(6):1565-73

Laurie Rambach, Julie Vincent, Veronique Lorgis, Sylvain Ladoire, Francois Ghiringhelli, Department of Medical Oncology, Centre Georges-François Leclerc, 21000 Dijon, France.

View Article

Download full-text PDF

Source
http://www.tijmu.edu.cn/picture/article/2/89/d4/72b72db84812
Web Search
http://www.wjgnet.com/1007-9327/full/v20/i6/1565.htm
Publisher Site
http://dx.doi.org/10.3748/wjg.v20.i6.1565DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3925865PMC
February 2014

Prolonged administration of adjuvant temozolomide improves survival in adult patients with glioblastoma.

Anticancer Res 2013 Aug;33(8):3467-74

Neuro-oncology Unit, Department of Neurology, Centre Hospitalier Universitaire, 29 Avenue du Maréchal Lattre de Tassigny, Nancy, 54035 Cedex, France.

View Article

Download full-text PDF

Source
August 2013

Metronomic cyclophosphamide with cisplatin and bevacizumab: a new chemotherapeutic regimen for refractory anaplastic ependymoma.

Anticancer Res 2012 Nov;32(11):5067-70

Departments of 1Medical Oncology, Georges-Francois Leclerc Cancer Center, 1 rue du professeur Marion, Dijon 21000, France.

View Article

Download full-text PDF

Source
November 2012

Anticancer therapy in patients with porphyrias: evidence today.

Expert Opin Drug Saf 2008 Mar;7(2):159-65

Medical Oncology Unit, CHU Minjoz, Bvd Fleming, 25000 Besancon, France.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1517/14740338.7.2.159DOI Listing
March 2008

[Pemetrexed development in oncology].

Bull Cancer 2007 ;94 Spec No Actualites:S142-8

Service d'oncologie médicale, centre hospitalier universitaire Jean-Minjoz, 25000 Besançon.

View Article

Download full-text PDF

Source
October 2007